CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

Launched by UNIVERSITY OF MANITOBA · Feb 2, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new virtual care platform called VIEWER to see if it can help reduce emergency room visits and hospital stays for patients with advanced Chronic Kidney Disease (CKD) Stage 5 or End Stage Renal Disease. The goal is to find out if using this platform alongside regular medical care can make patients feel safer and improve their overall care experience.

To participate in this trial, you need to be over 18 years old, be able to read and speak English, and have Stage 5 CKD with specific test results showing your kidney function is quite low. You should also be able to use a mobile app for self-monitoring your health, like taking your weight and blood pressure. If you join the study, you'll use the VIEWER app to help manage your condition and stay connected with your healthcare team. This trial is currently recruiting participants, and it's a great opportunity to contribute to research that could improve care for others with similar health challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • \>18 years of age
• • Patient or primary caregiver can read and speak English
• • Patient or patients substitute decision maker is able to provide informed consent
• • Patient or primary care giver cognitively and physically capable and willing to use the VIEWER mobile application and perform self-measurements (i.e. weight, BP, etc.)
• • Have stage 5 CKD (2 measurements of eGFR \<15ml/min/1.73m2); eGFR will be calculated with the CKD-EPI equation.
• • Followed in a multidisciplinary CKD clinic
• • Have \>40% chance of beginning dialysis in the next 2 years based on the Kidney Failure Risk Equation
• Exclusion Criteria:
• • Inability of self or caregiver assisted self-monitoring using VIEWER